Retrospective Analysis of Clinical Outcomes Associated With the Use of Pegfilgrastim On-body Injector in Patients Receiving Chemotherapy Requiring Granulocyte Colony-Stimulating Factor Support

Objectives: Pegfilgrastim is a granulocyte colony-stimulating factor (G-CSF) used as primary prophylaxis in patients receiving myelosuppressive chemotherapy regimens that have greater than 20% risk of developing febrile neutropenia (FN). Historically, pegfilgrastim has been administered 24 to 72 hou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hosp Pharm
Main Authors: Patel, Jolly, Rainess, Rebecca Ann, Benfield, Miranda J., Rogers, Kate M. L., Moore, Donald C., Larck, Chris, Arnall, Justin R.
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7958366/
https://ncbi.nlm.nih.gov/pubmed/33790481
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0018578719867659
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados